Amredobresib

Names

[ Name ]:
Amredobresib

Biological Activity

[Description]:

Amredobresib is a potent inhibitor of BET. Amredobresib inhibits the binding of bromodomains to acetylated lysines on histone H3 and H4 and thus acts as important regulators of gene transcription. Amredobresib is useful for the research of acute myeloid leukemia (AML) and cancer (extracted from patent WO2019145410A1 and WO2021175824A1)[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Epigenetics >> Epigenetic Reader Domain

[Target]

BET[1]

[References]

[1]. Ulrike Tontsch-Grunt, et al. Combination treatment of acute myeloid leukemia. Patent WO2019145410A1.

[2]. Shaonan Wang, et al. Method for administration of an anti cancer agent. Patent WO2021175824A1.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₆H₂₉N₉

[ Molecular Weight ]:
467.57

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.